FDA Pulls Avandia From US Pharmacies
The U.S. Food and Drug Administration announced Wednesday that it would restrict access to GlaxoSmithKline PLC's diabetes drug Avandia and pull it from retail pharmacies because of the drug's link to...To view the full article, register now.
Already a subscriber? Click here to view full article